Push for COVID-19 vaccine patent waiver isn’t a panacea: but it could nudge companies to share
Push for COVID-19 vaccine patent waiver isn’t a panacea: but it could nudge companies to share: shutterstock A new proposal, this time from the US, on how to open up access to vaccines against COVID-19 by relaxing patent rights, has added to an already complex and fraught debate between the World Trade Organisation’s 164 members. …
